Literature DB >> 15642427

Metastatic lymph node ratio as a prognostic factor in gastric cancer.

J M Rodríguez Santiago1, E Muñoz, M Martí, S Quintana, E Veloso, C Marco.   

Abstract

BACKGROUND: There is an association between the number of resected lymph node and the number of metastatic lymph nodes in gastric cancer, suggesting that pN category could be influenced by the extension of the lymphadenectomy. This study evaluates this association and proposes a comprehensive use of the ratio as prognostic factor.
METHOD: Review of 183 consecutive patients with gastric adenocarcinoma. The association between the number of resected lymph nodes and the number of metastatic lymph nodes was analysed and evaluated with other prognostic factors.
RESULTS: The number of lymph node metastases increased with the number of resected lymph nodes. The lymph node ratio was a better prognostic factor than the number of metastatic lymph nodes.
CONCLUSIONS: The metastatic lymph node ratio seems to be a good prognostic factor, but needs further evaluation.

Entities:  

Mesh:

Year:  2005        PMID: 15642427     DOI: 10.1016/j.ejso.2004.09.013

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  27 in total

1.  Prognostic impact of metastatic lymph node ratio on gastric cancer after curative distal gastrectomy.

Authors:  Chang-Ming Huang; Jian-Xian Lin; Chao-Hui Zheng; Ping Li; Jian-Wei Xie; Bi-Juan Lin; Jia-Bin Wang
Journal:  World J Gastroenterol       Date:  2010-04-28       Impact factor: 5.742

2.  Large metastatic lymph node size, especially more than 2 cm: independent predictor of poor prognosis in node-positive gastric carcinoma.

Authors:  O Cheong; S T Oh; B S Kim; J H Yook; J H Kim; J T Im; G C Park
Journal:  World J Surg       Date:  2008-02       Impact factor: 3.352

3.  Effect of lymphadenectomy extent on advanced gastric cancer located in the cardia and fundus.

Authors:  Chang-Ming Huang; Bi-Juan Lin; Hui-Shan Lu; Xiang-Fu Zhang; Ping Li; Jian-Wei Xie
Journal:  World J Gastroenterol       Date:  2008-07-14       Impact factor: 5.742

4.  Positive Lymph Node Ratio as an Indicator of Prognosis and Local Tumor Clearance in N3 Gastric Cancer.

Authors:  Shuhei Komatsu; Daisuke Ichikawa; Mahito Miyamae; Toshiyuki Kosuga; Kazuma Okamoto; Tomohiro Arita; Hirotaka Konishi; Ryo Morimura; Yasutoshi Murayama; Atsushi Shiozaki; Yoshiaki Kuriu; Hisashi Ikoma; Masayoshi Nakanishi; Hitoshi Fujiwara; Eigo Otsuji
Journal:  J Gastrointest Surg       Date:  2016-06-28       Impact factor: 3.452

5.  Metastatic lymph node ratio: a new staging system for gastric cancer.

Authors:  Roberto Persiani; Stefano Rausei; Vincenzo Antonacci; Alberto Biondi; Francesco Casella; Luigi Ciccoritti; Domenico D'Ugo
Journal:  World J Surg       Date:  2009-10       Impact factor: 3.352

6.  Determining of metastatic lymph node ratio in patients who underwent D2 dissection for gastric cancer.

Authors:  Ahmet Bilici; Mesut Seker; Bala Basak Oven Ustaalioglu; Burcak Yilmaz; Alper Doventas; Taflan Salepci; Mahmut Gumus
Journal:  Med Oncol       Date:  2009-11-03       Impact factor: 3.064

7.  Usefulness of the log odds of positive lymph nodes to predict and discriminate prognosis in gastric carcinomas.

Authors:  A Calero; J Escrig-Sos; F Mingol; A Arroyo; D Martinez-Ramos; M de Juan; J L Salvador-Sanchis; E Garcia-Granero; R Calpena; F J Lacueva
Journal:  J Gastrointest Surg       Date:  2015-01-06       Impact factor: 3.452

8.  Prognostic significance of the metastatic lymph node ratio in patients with gastric cancer.

Authors:  Sung Ryol Lee; Hyung Ook Kim; Byung Ho Son; Jun Ho Shin; Chang Hak Yoo
Journal:  World J Surg       Date:  2012-05       Impact factor: 3.352

9.  Comparison of four staging systems of lymph node metastasis in gastric cancer.

Authors:  Ming Zhang; Guanyu Zhu; Yan Ma; Yingwei Xue
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

10.  New metastatic lymph node ratio system reduces stage migration in patients undergoing D1 lymphadenectomy for gastric adenocarcinoma.

Authors:  Ugwuji N Maduekwe; Gregory Y Lauwers; Carlos Fernandez-Del-Castillo; David L Berger; Charles M Ferguson; David W Rattner; Sam S Yoon
Journal:  Ann Surg Oncol       Date:  2010-01-23       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.